Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

Patients with prior malignancy showed improved cancer-specific survival in metastatic colorectal cancer (mCRC), but prior skin tumors or malignancies diagnosed over five years earlier worsened ...

Bria-IMT combined with a checkpoint inhibitor improved overall survival in metastatic breast cancer compared to Trodelvy and chemotherapy. In triple-negative breast cancer, Bria-IMT showed a median ...

Metastatic breast cancer (MBC) or stage IV breast cancer is when cancer spreads beyond the breast and regional lymph nodes to distant sites like bones, liver, lungs or brain. Breast cancer cells ...

Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life. Surgery may be ...

Adding the investigational drug elraglusib to standard first-line gemcitabine and nab-paclitaxel (GnP) may extend the lives of some patients with metastatic pancreatic ductal adenocarcinoma (PDAC), ...

Zanzalintinib plus atezolizumab showed significant survival benefits over regorafenib in non-MSI-high metastatic colorectal cancer patients in the STELLAR-303 trial. The trial's safety profile was ...

Add Yahoo as a preferred source to see more of our stories on Google. Since the first Breast Cancer Awareness Month initiatives kicked off 40 years ago, major improvements have been made in treating ...